Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 21-30 of 34

Page
per page
  1. Vinorelbine ditartrate
    A3921 Vinorelbine ditartrate
    Summary: Anti-mitotic chemotherapy drug
      ≥33.7 mg/mL
  2. ENMD-2076 L-(+)-Tartaric acid
    A4129 ENMD-2076 L-(+)-Tartaric acid
    Summary: Aurora kinases inhibitor
      insoluble in EtOH; ≥175.8 mg/mL
  3. K03861
    B6042 K03861
    Summary: CDK2 inhibitor
      ≥50.2 mg/mL
  4. ISRIB
    B6093 ISRIB
    Summary: PERK signaling inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.03 mg/mL
  5. RI-2
    B5881 RI-2
    Target: RAD51
    Summary: Optimized reversible RAD51 inhibitor
      ≥21.65 mg/mL
  6. Mebendazole
    C4087 Mebendazole
    Summary: broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis
      insoluble in H2O; insoluble in EtOH; ≥13 mg/mL
  7. Eg5-I
    C5188 Eg5-I
    Summary: potent inhibitor of Eg5
      ≤1 mg/mL
  8. CFI-400945
    C5813 CFI-400945
    Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)
      insoluble in H2O; ≥109.8 mg/mL
  9. LDC000067
    B4754 LDC000067
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK9 inhibitor, novel and highly specific
      insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
  10. INH6
    B4757 INH6
    Summary: Hec1/Nek2 inhibitor, potent
      ≥32.2 mg/mL

Items 21-30 of 34

Page
per page